The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel Disease

BVES 在肠道修复计划和炎症性肠病中的作用

基本信息

  • 批准号:
    8921977
  • 负责人:
  • 金额:
    $ 2.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-18 至 2016-09-17
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Inflammatory bowel disease (IBD) affects approximately 1.4 million people in the United States, and carries numerous and severe complications, such as fistulas, strictures, and heightened risk of colorectal cancer. The purported explanation of IBD is a persistent inappropriate activation of the immune system possibly triggered by the microbiota. Indeed, the intestinal epithelium is continually exposed to and challenged by a tremendous antigen load. Remarkably, the intestinal epithelium maintains homeostasis despite continually sustaining injury. Defects in wound healing programs are emerging as playing a key role in contributing to IBD pathogenesis. Wound healing programs remain complex, however, and the genetic factors in play have yet to be firmly established. Epithelial-to-mesenchymal transition (EMT) is a critical process by which epithelial cells acquire more mesenchymal phenotypes, such as greater motility and anchorage independence, and it is pivotal in injury repair. Blood vessel epicardial substance (BVES) is a tight junction associated protein discovered in a cDNA screen of a developing heart. Recently, it has been demonstrated that loss of BVES promotes EMT in corneal epithelial and malignant cell lines. Furthermore, knocking down BVES expression disrupts cell-to-cell adhesion, accelerates migration, invasion, and anchorage independent growth and increases proliferation. Interestingly, aberrant EMT programs have recently been implicated in the pathogenesis of IBD. Given these observations we postulate that BVES could contribute to the pathogenesis of IBD. In support of this, we found that BVES levels in IBD patients were inversely correlated to disease severity. Taken together, we hypothesize that BVES plays a critical role in epithelial repair programs. We propose to test this hypothesis and expand our understanding of how BVES informs intracellular signaling pathways by two focused specific aims. First, we will induce intestinal injury in BVES-/- mice using two complementary animals models of colitis: dextran sodium sulfate (DSS) and Citrobacter rodentium infection. These will allow us to determine whether BVES deficient mice are more susceptible to colitis. Second, we have commissioned a yeast-two-hybrid screen and identified PR61-alpha, a phosphatase linked to cell growth and proliferation, as a binding partner of BVES. We will test the functional significance of this interaction by mapping the binding domains and by determining how disrupting the interaction affects BVES-dependent phenotypes and intracellular signaling. Our proposed studies will define the role of BVES in IBD pathology and injury repair programs. Importantly, clarifying the role of BVES could potentially create new avenues of therapy.
描述(申请人提供):炎症性肠病(IBD)在美国影响着大约140万人,并带有许多严重的并发症,如瘘管、狭窄和结直肠癌的高风险。所谓的IBD的解释是一种持续的、不适当的免疫系统激活,可能是由微生物群引发的。事实上,肠道上皮不断地暴露在巨大的抗原负荷下并受到挑战。值得注意的是,尽管不断受到损伤,肠上皮仍保持动态平衡。伤口愈合程序中的缺陷在IBD的发病机制中发挥着关键作用。然而,伤口愈合程序仍然很复杂,发挥作用的遗传因素尚未得到确定。上皮向间充质转化(EMT)是上皮细胞获得更多间充质表型的关键过程,如更大的运动性和锚定独立性,在损伤修复中起关键作用。血管心外膜物质(BVES)是在心脏发育过程中发现的一种紧密连接相关蛋白。最近的研究表明,BVES的缺失促进了角膜上皮细胞和恶性细胞系的EMT。此外,下调BVES的表达会破坏细胞间的黏附,加速迁移、侵袭和锚定非依赖性生长,并增加增殖。有趣的是,异常的EMT程序最近被认为与IBD的发病机制有关。鉴于这些观察结果,我们推测BVES可能参与IBD的发病机制。为了支持这一点,我们发现IBD患者的BVES水平与疾病严重程度呈负相关。综上所述,我们假设BVES在上皮修复程序中起着关键作用。我们建议检验这一假设,并通过两个特定的目标来扩大我们对BVES如何通知细胞内信号通路的理解。首先,我们将使用两种互补的结肠炎动物模型:葡聚糖硫酸钠(DSS)和轮状柠檬酸杆菌感染来诱导BVES-/-小鼠的肠道损伤。这将使我们能够确定BVES缺陷小鼠是否更容易患结肠炎。其次,我们委托进行了酵母双杂交筛选,并确定与细胞生长和增殖相关的磷酸酶PR61-α是BVES的结合伙伴。我们将通过绘制结合结构域并确定破坏相互作用如何影响BVES依赖的表型和细胞内信号,来测试这种相互作用的功能意义。我们建议的研究将确定BVES在IBD病理和损伤修复计划中的作用。重要的是,阐明BVES的作用可能会创造新的治疗途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bobak Parang其他文献

Bobak Parang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bobak Parang', 18)}}的其他基金

The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel Disease
BVES 在肠道修复计划和炎症性肠病中的作用
  • 批准号:
    8572975
  • 财政年份:
    2012
  • 资助金额:
    $ 2.71万
  • 项目类别:
The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel Disease
BVES 在肠道修复计划和炎症性肠病中的作用
  • 批准号:
    8724489
  • 财政年份:
    2012
  • 资助金额:
    $ 2.71万
  • 项目类别:
The Role of BVES in Intestinal Repair Programs and Inflammatory Bowel Disease
BVES 在肠道修复计划和炎症性肠病中的作用
  • 批准号:
    8453603
  • 财政年份:
    2012
  • 资助金额:
    $ 2.71万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 2.71万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了